191 related articles for article (PubMed ID: 33966135)
1. Expression profile of PU.1 in CD4
Xiang N; Fang X; Sun XG; Zhou YB; Ma Y; Zhu C; Li XP; Wang GS; Tao JH; Li XM
Clin Exp Med; 2021 Nov; 21(4):621-632. PubMed ID: 33966135
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
3. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
[TBL] [Abstract][Full Text] [Related]
5. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
6. Expression of Ets-1 and FOXP3 mRNA in CD4(+)CD25 (+) T regulatory cells from patients with systemic lupus erythematosus.
Xiang N; Li XP; Li XM; Wang GS; Tao JH; Pan HF; Fang X; Ma Q; Yu N
Clin Exp Med; 2014 Nov; 14(4):375-81. PubMed ID: 24221578
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.
Cui HD; Qi ZM; Yang LL; Qi L; Zhang N; Zhang XL; Du SY; Jiang Y
Clin Exp Immunol; 2011 Aug; 165(2):163-71. PubMed ID: 21635228
[TBL] [Abstract][Full Text] [Related]
8. Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus.
Ouyang H; Shi Y; Liu Z; Feng S; Li L; Su N; Lu Y; Kong S
Mol Med Rep; 2013 Mar; 7(3):1031-7. PubMed ID: 23291628
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
10. Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients.
Qin WZ; Chen LL; Pan HF; Leng RX; Zhai ZM; Wang C; Li RJ; Wang S; Wang HP; Ye DQ
Clin Exp Med; 2011 Dec; 11(4):245-50. PubMed ID: 21487830
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
12. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
[TBL] [Abstract][Full Text] [Related]
13. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.
Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z
J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023
[TBL] [Abstract][Full Text] [Related]
14. Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients.
Garcia-Rodriguez S; Callejas-Rubio JL; Ortego-Centeno N; Zumaquero E; Ríos-Fernandez R; Arias-Santiago S; Navarro P; Sancho J; Zubiaur M
Mediators Inflamm; 2012; 2012():495934. PubMed ID: 23125486
[TBL] [Abstract][Full Text] [Related]
15. [Abnormality and significance of interleukin-9 and CD4(+)interleukin-9(+) T-cells in peripheral blood of patients with systemic lupus erythematosus].
Ouyang H; Shi YB; Su N; Li LY
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):99-103. PubMed ID: 23648344
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between the changes of innate lymphoid cells in peripheral blood of systemic lupus erythematosus and its clinical significance].
Chu H; Fang X; Tan Z; Zhen X; Wu RL; Li XP; Wang GS; Wang YP; Li XM
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):169-173. PubMed ID: 30669757
[No Abstract] [Full Text] [Related]
17. Levels of base excision repair proteins in CD4
Zhou X; Wu X; Deng M; Qiu Y; Zhou S; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1655-1662. PubMed ID: 36748375
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T-cells and their impacts on cytokine profile of end-stage renal disease patients suffering from systemic lupus erythematosus.
Fathi F; Atapour A; Eskandari N; Keyhanmehr N; Hafezi H; Mohammadi S; Motedayyen H
Int J Immunopathol Pharmacol; 2019; 33():2058738419863238. PubMed ID: 31280608
[TBL] [Abstract][Full Text] [Related]
19. The decreased frequency of SIGIRR-positive CD4+ T cells in peripheral blood of patients with SLE and its correlation with disease activity.
Wang DY; Su C; Chen GM; Pan HF; Wang FM; Liu GL; Hao L; Wang DG; Ye DQ
Mol Biol Rep; 2015 Feb; 42(2):423-30. PubMed ID: 25287661
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus.
El-Akhras BA; Talaat RM; El-Masry SA; Bassyouni IH; El-Sayed IH; Ali YB
Int J Immunopathol Pharmacol; 2023; 37():3946320231154998. PubMed ID: 36740569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
